Skip to main content

Table 1 The correlation between clinicopathologic characteristics and HDLPO in the training cohort

From: A new use for an old index: preoperative high-density lipoprotein predicts recurrence in patients with hepatocellular carcinoma after curative resections

  

Number (n = 189)

Low-HDLPO group (n = 32)

High-HDLPO group (n = 157)

P value

Sex

Male

163

28

135

0.821a

 

Female

26

4

22

Age

≤50

69

13

56

0.596

 

>50

120

19

101

Tumor number

Single

151

26

125

0.833

 

Multiple

38

6

32

Tumor size

≤5

120

18

102

0.351

 

>5

69

14

55

Tumor encapsulation

None

115

17

98

0.326

 

Complete

74

15

59

Satellite lesions

No

166

27

139

0.524a

 

Yes

23

5

18

Vascular invasion

No

118

17

101

0.321

 

Yes

71

15

56

Tumor grade

I-II

117

14

103

0.020

 

III-IV

72

18

54

Child-Pugh grade

A

178

29

149

0.347a

 

B

11

3

8

BCLC stage

0 + A

138

24

114

0.781

 

B + C

51

8

43

AFP,μg/L

≤400

139

21

118

0.265

 

>400

50

11

39

ALT,μg/L

≤40

178

32

146

0.124a

 

>40

11

0

11

GGT,IU/L

≤54

110

17

93

0.559

 

>54

79

15

64

 

HbsAg

Negative

23

1

22

0.100a

 

Positive

166

31

135

 

Recurrence

No

100

11

89

0.032

 

Yes

89

21

68

 
  1. Abbreviations: AFP, α-fetoprotein; ALT, alanine aminotransferase; GGT, γ-glutamyl transpeptadase; HBsAg, hepatitis B surface antigen; BCLC, Barcelona Clinic Liver Cancer aFisher’s exact test